Emmaus Life Sciences Inc
OTC:EMMA
Emmaus Life Sciences Inc
OTC:EMMA
Price:
0.0152
USD
-0.65%
Market Cap:
$970.8k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Emmaus Life Sciences Inc
OTC:EMMA
|
US |
|
Composite Alliance Group Inc
XTSX:CAG
|
CA |
|
J
|
Jin Medical International Ltd
NASDAQ:ZJYL
|
CN |
|
W
|
Webuy Global Ltd
NASDAQ:WBUY
|
KY |
|
M
|
Minera Alamos Inc
OTC:MAIFF
|
CA |
|
Frontier IP Group PLC
LSE:FIPP
|
UK |
|
MKF Krasnyi Oktyabr' PAO
MOEX:KROT
|
RU |
|
C
|
C Cheng Holdings Ltd
HKEX:1486
|
HK |
|
C
|
Cashbuild Ltd
JSE:CSB
|
ZA |
|
V
|
Viglacera Tien Son JSC
VN:VIT
|
VN |
|
D
|
Daejoo Inc
KOSDAQ:003310
|
KR |
|
W
|
Watt's SA
SGO:WATTS
|
CL |
|
Telus Corp
TSX:T
|
CA |
|
China Resources Power Holdings Co Ltd
HKEX:836
|
HK |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of EMMA.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
EMMA
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
EMMA Competitors Multiples
Emmaus Life Sciences Inc Competitors
Emmaus Life Sciences Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Emmaus Life Sciences Inc
OTC:EMMA
|
970.8k USD | 0.1 | -0.1 | -5.1 | -5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
869B USD | 14 | 44.1 | 29.7 | 31.7 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
588.6B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
233B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.7B USD | 4.6 | 16.4 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.9B CHF | 5.4 | 21.7 | 13.4 | 17.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
159.7B USD | 2.6 | 20.8 | 7.9 | 10.5 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.1B USD | 2.6 | 17.7 | 7.4 | 9.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
